Inflammatory aneurysm of the abdominal aorta in a patient treated with ropinirole (Q43091044)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 April 2010

Language	Label	Description	Also known as
English	Inflammatory aneurysm of the abdominal aorta in a patient treated with ropinirole	scientific article published on 21 April 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Inflammatory aneurysm of the abdominal aorta in a patient treated with ropinirole (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

0 references

author name string

Dimitrios Parissis

1

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Athanasia Papachristodoulou

2

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Athanasios Dimitriadis

3

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

publication date

21 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Journal of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

257

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

1582-1584

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine(2B) receptor agonists: implications for drug safety assessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis and management of pergolide-induced fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson's disease: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retroperitoneal fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pleural effusion and thickening due to cabergoline use in a patient with Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrosis associated with dopamine agonist therapy in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic periaortitis: a fibro-inflammatory disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00415-010-5568-6

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43091044&oldid=2224230957"